Notable
NefXtend · Extended TARPEYO® Treatment Beyond 9 Months · Primary IgA Nephropathy
Primary completion pushed from May 29, 2026 to Mar 2027
Also in this update: Enrollment closed, study ongoing; Study completion pushed from Nov 2027 to Feb 2028
Calliditas Therapeutics ABPhase 4 NCT06712407 Registry history of NCT06712407 on ClinicalTrials.gov (opens the registry)